​
​

Repare Therapeutics (RPTX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Repare Therapeutics Revenue Highlights

00

Main Geography (Y)

UNITED STATES

Repare Therapeutics Revenue by Period

Repare Therapeutics Revenue by Year

DateRevenueChange
2023-12-31--100.00%
2022-12-31$131.83M1634.61%
2021-12-31$7.60M5529.63%
2020-12-31$135.00K100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31--

Repare Therapeutics generated - in revenue during NA 2023, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Repare Therapeutics Revenue by Quarter

DateRevenueChange
2024-09-30--100.00%
2024-06-30$1.07M-97.95%
2024-03-31$52.40M301.66%
2023-12-31$13.05M504.31%
2023-09-30$2.16M-92.86%
2023-06-30$30.25M432.74%
2023-03-31$5.68M-68.80%
2022-12-31$18.20M-83.83%
2022-09-30$112.55M16475.11%
2022-06-30$679.00K66.42%
2022-03-31$408.00K-94.07%
2021-12-31$6.88M2373.74%
2021-09-30$278.00K-0.36%
2021-06-30$279.00K68.07%
2021-03-31$166.00K22.96%
2020-12-31$135.00K100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31--

Repare Therapeutics generated - in revenue during Q3 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Repare Therapeutics Revenue Breakdown

Repare Therapeutics Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21
UNITED STATES$26.10M$15.20M-
SWITZERLAND$14.50M$116.60M-
JAPAN$10.50M--
U S--$7.60M

Repare Therapeutics's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (51.08%), SWITZERLAND (28.38%), and JAPAN (20.55%).

Repare Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ACCDAccolade$414.29M$106.36M
NRIXNurix Therapeutics$76.99M$12.59M
MASS908 Devices$50.23M$16.77M
RLAYRelay Therapeutics$25.55M-
FUSNFusion Pharmaceuticals$2.07M-
RPTXRepare Therapeutics--

RPTX Revenue FAQ

What is Repare Therapeutics’s yearly revenue?

Repare Therapeutics's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. The company's yearly revenue for 2022 was $131.83M, representing an increase of 1634.61% compared to 2021. RPTX's yearly revenue for 2021 was $7.6M, representing an increase of 5529.63% compared to 2020.

What is Repare Therapeutics’s quarterly revenue?

Repare Therapeutics's quarterly revenue for Q3 2024 was $0, a -100.00% decrease from the previous quarter (Q2 2024), and a -100.00% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $1.07M, a -97.95% decrease from the previous quarter (Q1 2024), and a -96.45% decrease year-over-year (Q2 2023). RPTX's quarterly revenue for Q1 2024 was $52.4M, a 301.66% increase from the previous quarter (Q4 2023), and a 822.93% increase year-over-year (Q1 2023).

What is Repare Therapeutics’s revenue growth rate?

Repare Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -100.00%, and for the last 5 years (2019-2023) was 0%.